Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Kimko

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Pharmacokinetics|January 11, 2000
Pharmacokinetics and clinical effectiveness of methylphenidateH C Kimko, J T Cross, D R Abernethy
Annual Review of Pharmacology and Toxicology|June 3, 2000
Simulation of clinical trialsN H Holford, H C Kimko, J P Monteleone, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic modelH C Kimko, S S Reele, N H Holford, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Pharmacokinetics|January 11, 2000
Pharmacokinetics and clinical effectiveness of methylphenidateH C Kimko, J T Cross, D R Abernethy
Annual Review of Pharmacology and Toxicology|June 3, 2000
Simulation of clinical trialsN H Holford, H C Kimko, J P Monteleone, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by simulation with a population pharmacokinetic and pharmacodynamic modelH C Kimko, S S Reele, N H Holford, et al.
Pageof 1